AACR Cancer Progress Report 2024
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Screening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the Report
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreAACR grantee and NextGen Star Chemtai Mungo, MD, MPH, is developing an innovative self-treatment strategy for cervical precancer that could save lives in underserved areas.
Read AACR StoriesCertain diseases and disorders can increase the risk of developing childhood liver cancer, a rare malignancy in children and adolescents. October is Liver Cancer Awareness Month.
Learn MoreIn this episode of the Believe in Progress podcast, our host Mitch Stoller, AACR’s Chief Philanthropic Officer, speaks with former Philadelphia Mayor Michael A. Nutter.
Listen and SubscribeRead about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
